Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 55 | $208,445,023 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Aug 2024 17:00 | ABBV | AbbVie Inc | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | 05 Aug 2024 | Sale | 66,500 | 186.52 | 12,403,580 | D |
19 Jul 2024 16:40 | ABBV | AbbVie Inc | GONZALEZ RICHARD A | EXECUTIVE CHAIRMAN OF BOARD | 17 Jul 2024 | Sale | 282,845 | 175 | 49,497,875 | D |
22 Mar 2024 17:00 | ABBV | AbbVie Inc | DONOGHOE NICHOLAS | EVP, CHIEF BUS/STRAT OFFICER | 20 Mar 2024 | Sale | 21,082 | 176.3 | 3,716,757 | D |
20 Mar 2024 17:00 | ABBV | AbbVie Inc | STEWART JEFFREY RYAN | EVP, CHIEF COMMERCIAL OFFICER | 18 Mar 2024 | Sale | 5,099 | 179.03 | 912,874 | D |
20 Mar 2024 17:00 | ABBV | AbbVie Inc | STEWART JEFFREY RYAN | EVP, CHIEF COMMERCIAL OFFICER | 18 Mar 2024 | Sale | 27,740 | 178.69 | 4,956,861 | D |
20 Mar 2024 17:00 | ABBV | AbbVie Inc | STEWART JEFFREY RYAN | EVP, CHIEF COMMERCIAL OFFICER | 18 Mar 2024 | Sale | 26,110 | 178.85 | 4,669,774 | D |
05 Mar 2024 17:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2024 | Sale | 20,127 | 177.71 | 3,576,769 | D |
05 Mar 2024 17:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2024 | Sale | 9,853 | 176.35 | 1,737,577 | D |
05 Mar 2024 17:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2024 | Sale | 30,288 | 177.71 | 5,382,480 | D |
05 Mar 2024 17:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2024 | Sale | 15,412 | 176.4 | 2,718,677 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | REENTS SCOTT T | EVP, CHIEF FINANCIAL OFFICER | 23 Feb 2024 | Sale | 14,140 | 177.44 | 2,509,002 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | BUCKBEE KEVIN K | SVP, CONTROLLER | 29 Feb 2024 | Sale | 5,144 | 176.65 | 908,688 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | MICHAEL ROBERT A. | PRES & CHIEF OPERATING OFFICER | 29 Feb 2024 | Sale | 47,319 | 176.46 | 8,349,911 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | MICHAEL ROBERT A. | PRES & CHIEF OPERATING OFFICER | 29 Feb 2024 | Sale | 21,560 | 176.44 | 3,804,046 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 29 Feb 2024 | Sale | 3,387 | 178.04 | 603,021 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 29 Feb 2024 | Sale | 6,504 | 177.05 | 1,151,533 | D |
01 Mar 2024 17:50 | ABBV | AbbVie Inc | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | 28 Feb 2024 | Sale | 138,616 | 177.27 | 24,572,458 | D |
27 Feb 2024 17:10 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 23 Feb 2024 | Sale | 13,753 | 177.51 | 2,441,295 | D |
23 Feb 2024 17:00 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, CHIEF OPERATIONS OFFICER | 21 Feb 2024 | Sale | 52,870 | 173.71 | 9,184,048 | D |
28 Dec 2023 17:00 | ABBV | AbbVie Inc | DONOGHOE NICHOLAS | EVP, CHIEF BUS/STRAT OFFICER | 26 Dec 2023 | Sale | 2,912 | 154.72 | 450,545 | D |
02 Aug 2023 17:07 | ABBV | AbbVie Inc | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | 01 Aug 2023 | Sale | 60,000 | 148.58 | 8,914,800 | D |
02 Aug 2023 17:07 | ABBV | AbbVie Inc | GONZALEZ RICHARD A | CHAIRMAN OF THE BOARD AND CEO | 31 Jul 2023 | Sale | 18,500 | 149.15 | 2,759,275 | D |
09 May 2023 17:01 | ABBV | AbbVie Inc | AUSTIN ROXANNE S | Director | 17 Feb 2023 | Sale A | 6,222 | 150.5 | 936,411 | D |
27 Apr 2023 17:00 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 25 Apr 2023 | Sale | 6,130 | 165 | 1,011,450 | D |
19 Apr 2023 17:00 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 17 Apr 2023 | Sale | 500 | 162.04 | 81,020 | D |
19 Apr 2023 17:00 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 17 Apr 2023 | Sale | 6,999 | 161.64 | 1,131,318 | D |
05 Apr 2023 17:00 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 03 Apr 2023 | Sale | 15,002 | 160.03 | 2,400,770 | D |
05 Apr 2023 17:00 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 03 Apr 2023 | Sale | 3,520 | 160 | 563,200 | D |
15 Mar 2023 17:00 | ABBV | AbbVie Inc | STEWART JEFFREY RYAN | EVP, CHIEF COMMERCIAL OFFICER | 13 Mar 2023 | Sale | 31,315 | 152.27 | 4,768,335 | D |
15 Mar 2023 17:00 | ABBV | AbbVie Inc | STEWART JEFFREY RYAN | EVP, CHIEF COMMERCIAL OFFICER | 13 Mar 2023 | Sale | 21,810 | 152.3 | 3,321,663 | D |
02 Mar 2023 17:07 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 01 Mar 2023 | Sale | 15,003 | 155 | 2,325,465 | D |
02 Mar 2023 17:06 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 01 Mar 2023 | Sale | 805 | 153.38 | 123,471 | D |
02 Mar 2023 17:06 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 01 Mar 2023 | Sale | 11,330 | 153.06 | 1,734,170 | D |
02 Mar 2023 17:04 | ABBV | AbbVie Inc | REENTS SCOTT T | EVP, CHIEF FINANCIAL OFFICER | 01 Mar 2023 | Sale | 850 | 153.38 | 130,373 | D |
02 Mar 2023 17:04 | ABBV | AbbVie Inc | REENTS SCOTT T | EVP, CHIEF FINANCIAL OFFICER | 01 Mar 2023 | Sale | 15,092 | 153.06 | 2,309,982 | D |
02 Mar 2023 17:01 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, OPERATIONS | 01 Mar 2023 | Sale | 780 | 153.39 | 119,644 | D |
02 Mar 2023 17:01 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, OPERATIONS | 01 Mar 2023 | Sale | 9,220 | 153.05 | 1,411,121 | D |
02 Mar 2023 17:01 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, OPERATIONS | 01 Mar 2023 | Sale | 26,990 | 155 | 4,183,450 | D |
02 Mar 2023 16:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2023 | Sale | 16,746 | 153.62 | 2,572,521 | D |
02 Mar 2023 16:30 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 01 Mar 2023 | Sale | 27,395 | 153.0784 | 4,193,583 | D |
22 Feb 2023 17:00 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 21 Feb 2023 | Sale | 3,933 | 151.29 | 595,024 | D |
22 Feb 2023 17:00 | ABBV | AbbVie Inc | SIATIS PERRY C | EVP, GC AND SECRETARY | 21 Feb 2023 | Sale | 3,431 | 150.73 | 517,155 | D |
21 Feb 2023 18:16 | ABBV | AbbVie Inc | AUSTIN ROXANNE S | Director | 17 Feb 2023 | Sale | 10,000 | 150.5 | 1,505,000 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 400 | 151.34 | 60,536 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 567 | 150.78 | 85,492 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 7,646 | 151.29 | 1,156,763 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 6,533 | 150.74 | 984,784 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 7,780 | 151.28 | 1,176,958 | D |
21 Feb 2023 18:14 | ABBV | AbbVie Inc | STROM CARRIE C | SVP & PRES GLOBAL ALLERG AESTH | 21 Feb 2023 | Sale | 5,615 | 150.71 | 846,237 | D |
21 Feb 2023 18:13 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, OPERATIONS | 17 Feb 2023 | Sale | 10,754 | 150.05 | 1,613,638 | D |
21 Feb 2023 18:13 | ABBV | AbbVie Inc | SALEKI-GERHARDT AZITA | EVP, OPERATIONS | 17 Feb 2023 | Sale | 14,246 | 149.13 | 2,124,506 | D |
21 Feb 2023 18:12 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 21 Feb 2023 | Sale | 8,420 | 151.29 | 1,273,862 | D |
21 Feb 2023 18:12 | ABBV | AbbVie Inc | SORG ELAINE K. | SVP, US COMMERCIAL OPERATIONS | 21 Feb 2023 | Sale | 6,901 | 150.74 | 1,040,257 | D |
14 Dec 2022 17:06 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 12 Dec 2022 | Sale | 3,075 | 164.1 | 504,608 | D |
14 Dec 2022 17:06 | ABBV | AbbVie Inc | RICHMOND TIMOTHY J. | EVP, CHIEF HR OFFICER | 12 Dec 2022 | Sale | 39,295 | 163.39 | 6,420,410 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)